AI-generated content for informational purposes only. Not financial advice. Always do your own research.

Om

Corteva Agriscience (NYSE: CTVA) er et rendyrket landbruksselskap og en av verdens ledende leverandører av såvarer og plantevernprodukter, utskilt fra DowDuPont i 2019 for å fokusere utelukkende på å fremme landbruksproduktivitet. Selskapets såvaresegment tilbyr en bred portefølje av kimplasma og egenskaper i mais, soyabønner og andre avlinger under merkene Pioneer og Brevant, mens plantevernsegmentet leverer ugressmidler, insektmidler og soppmidler til bønder globalt. Cortevas dedikerte fokus på landbruksinnovasjon, inkludert digitale landbruksverktøy og biologiske avlingsløsninger, posisjonerer det som en direkte investering i fremtiden for matproduksjon og bærekraftig landbrukspraksis.

Landbruksaksjer

Corteva Agriscience er et rent landbruksselskap fokusert på frøgenetikk og avlingsbeskyttelsesprodukter, og gir investorer direkte eksponering mot gårdsnivåinnovasjon inkludert avansert germplasma, traitteknologier og bærekraftige jordbruksløsninger.

AgriTech-aksjer

Corteva er et rent landbruksselskap og ledende global leverandør av frø- og avlingsbeskyttelsesprodukter, skilt ut fra DowDuPont for å fokusere på landbruksinnovasjon og produktivitet.

Key Financials CTVA

Pris $75.03
Endring (1D) +1.24%
Endring (30D) +11.93%
Endring (60D) +17.45%
Endring (90D) +16.69%
Endring (180D) +6.70%
Endring (1Y) +20.90%
Endring (5Y) +72.76%
P/E-forhold 24.36
EPS (TTM) $3.08
52-ukers rekkevidde $53.40 — $77.41
50-dagers MA $69.55
Volum 3.50M

Data updated Feb 15 · Source: Twelve Data

4.5
2 reviews
Performance
4.5
Fundamentals
4.4
Management Quality
4.4
Risk Profile
4
Valuation
3.8
Claude Opus 4.6
AI Review
4.4/5

Corteva Agriscience, spun off from DowDuPont in 2019, stands as one of the world's leading pure-play agricultural companies with dominant positions in both crop protection and seed technologies. The stock has shown strong momentum, trading near its 52-week high of $77.41 with a 20.9% gain over the past year and impressive 72.8% appreciation over five years.

The bull case centers on Corteva's robust R&D pipeline in biologicals, gene editing, and crop protection innovation, along with pricing power driven by global food security demands. Its dual seed/crop protection platform provides diversification within agriculture. EPS of $3.08 reflects solid profitability, and management has been disciplined with share buybacks.

The bear case includes a P/E of 24.36, which is elevated relative to agricultural peers, suggesting the stock prices in considerable growth expectations. Cyclical exposure to commodity prices, weather variability, and farmer purchasing decisions creates earnings volatility. Regulatory headwinds on certain chemistries and competitive pressure from generics remain ongoing risks.

Overall, Corteva represents a high-quality agricultural franchise with strong innovation credentials, though current valuation demands continued execution on growth initiatives.

Performance
4.5
Fundamentals
4.4
Management Quality
4.4
Risk Profile
4
Valuation
3.8
Feb 15, 2026
Gemini 3 Pro Preview
AI Review
4.6/5

Corteva Agriscience stands out as a premier pure-play vehicle for investors seeking exposure to the global agriculture sector. Commanding a formidable position in both seed technology and crop protection, the company benefits directly from the secular trend of increasing global food demand and the need for yield enhancement. With the stock trading near its 52-week high of $77.41 and sitting comfortably above its 50-day moving average, market sentiment remains bullish. The current P/E ratio of 24.1x reflects a premium valuation, justified by its specialized focus and robust R&D pipeline compared to more diversified competitors. However, investors should remain mindful of the cyclical nature of the agricultural economy, where fluctuations in commodity prices can impact farmer spending power. Despite these risks, Corteva's solid earnings performance and strategic operational efficiencies make it a compelling, albeit fully valued, core holding for long-term agricultural portfolios.

Feb 11, 2026
Corteva Agriscience Screenshot

Added: Feb 10, 2026

corteva.com

Latest from Otrai